- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05456464
Fatigue and Sleep Quality in Multiple Sclerosis Patients
August 30, 2023 updated by: Zülfünaz ÖZER, Istanbul Sabahattin Zaim University
Fatigue and Sleep Quality in Multiple Sclerosis Patients: Does Reiki Application Affect?
This study was planned to examine the effect of reiki application on fatigue and sleep quality in patients with multiple sclerosis.
Study Overview
Detailed Description
Fatigue and Sleep Quality in Multiple Sclerosis Patients: Does Reiki Application Affect?
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Güneydoğu Anadolu Bölgesi
-
Istanbul, Güneydoğu Anadolu Bölgesi, Turkey, 340340
- Istanbul Sabahattin Zaim University, Faculty of Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being over 18 years old
- Volunteering to participate in the research
- Having the ability to use technological tools
- Not using Reiki and similar integrative treatment methods
- Not having a verbal communication disability (hearing and speaking)
- Not having a diagnosed psychiatric disorder
- Patients who have been treated for MS for more than three months
- Having a scale score of >5 on the Piper Fatigue Scale
- A score of >5 on the Pittsburgh Sleep Quality Scale
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Routine maintenance will be applied
|
|
|
Experimental: Reiki
The researcher, a second-degree Reiki therapist, performed the Reiki therapy.
Patients were told to lie comfortably on their backs after they were informed about the therapy.
Each of the 7 Reiki hand positions was applied sequentially.
Each of the hand positions took 2-3 minutes, requiring 30-40 minutes in total.
|
Reiki is applied touching the energy centers of the body (chakras).
There are seven main and many small chakras on a body.
Chakras are located on the front and back sides of the body in a vertical line that runs along the middle of the body in humans.
A complete Reiki therapy includes all the chakras and organs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Piper Fatigue Scale
Time Frame: At the end of Session 1(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items).
Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints.
Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.
|
At the end of Session 1(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
|
The Piper Fatigue Scale
Time Frame: At the end of Session 7(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items).
Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints.
Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.
|
At the end of Session 7(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: At the end of Session 1(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
The PSQI is a valid and consistent survey comprising of 19 questions to assess quality and amount of sleep and the existence of a sleep disorder and its level in the previous month.
The scale was adapted into the Turkish language by Agargün et al. (1996).
The scale consists of seven components that assess patients subjective sleep quality, sleep delay, use of sleeping medication and disfunction in daily activities.
Each item scores in the range 0-3 points and the total score of the seven components gives the total PSQI score.
The total score has a value between 0-21 and a high total score demonstrates a poor quality of sleep.
A total PSQI score which is ≤5 indicates "good sleep", and a score which is >5 indicates "poor sleep"
|
At the end of Session 1(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: At the end of Session 7(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
The PSQI is a valid and consistent survey comprising of 19 questions to assess quality and amount of sleep and the existence of a sleep disorder and its level in the previous month.
The scale was adapted into the Turkish language by Agargün et al. (1996).
The scale consists of seven components that assess patients subjective sleep quality, sleep delay, use of sleeping medication and disfunction in daily activities.
Each item scores in the range 0-3 points and the total score of the seven components gives the total PSQI score.
The total score has a value between 0-21 and a high total score demonstrates a poor quality of sleep.
A total PSQI score which is ≤5 indicates "good sleep", and a score which is >5 indicates "poor sleep"
|
At the end of Session 7(In the first week, the first session will be face-to-face and the other sessions will be online for 4 days. 1 online session will be given on the first day of the 2nd, 3rd and 4th week. A total of 7 sessions of Reiki will begiven)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Zülfünaz Özer, PhD, Istanbul Sabahattin Zaim University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Actual)
August 8, 2022
Study Completion (Actual)
September 30, 2022
Study Registration Dates
First Submitted
July 5, 2022
First Submitted That Met QC Criteria
July 12, 2022
First Posted (Actual)
July 13, 2022
Study Record Updates
Last Update Posted (Actual)
August 31, 2023
Last Update Submitted That Met QC Criteria
August 30, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6812
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Reiki
-
University of YalovaCompletedNursing | Reiki | İntensive CareTurkey
-
University of YalovaCompleted
-
Mardin Artuklu UniversityCompleted
-
Sultan ÇEÇENCompleted
-
Mersin UniversityTübitakRecruiting
-
Ohio State UniversityCompletedMechanical Ventilation Complication | Complementary Health ApproachUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Autologous Stem Cell TransplantUnited States
-
Ondokuz Mayıs UniversityOndokuz Mayıs UniversityCompleted
-
TC Erciyes UniversityRecruitingDiabetic NeuropathyTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedNeuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4Turkey